body·mind·state
← Back to Events
🔬 Clinical Trial

New Trial: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer

📅 2026-06-23

The PEARL-C1 trial is a phase II open-label trial. Participants will receive a single high-dose (25 mg) of psilocybin in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy....

BMS
Body Mind State EditorialJune 23, 2026

Trial Overview

NCT ID: NCT07048743 Phase: PHASE2 Enrollment Target: 15 Status: Recruiting

The PEARL-C1 trial is a phase II open-label trial. Participants will receive a single high-dose (25 mg) of psilocybin in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy.

Why This Matters

[Draft — editorial context needed]

Source

Continue Reading

🔬 Clinical Trial

New Trial: Feasibility of Breathwork Intervention With Older Adults After Knee Surgery

Postoperative complications after surgical procedures, including following total knee arthroplasty (TKA), have a negative impact on the health and well-being of surgical patients. Older adults (≥65 years) are particularly vulnerable to postoperative...

1 min read🔬 Clinical Trial

New Trial: Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

The core objective of this study is to enhance the translational potential of this electroencephalogram (EEG) biomarker by using ketamine(KET)-induced gamma potentiation as a prognostic marker of 4-week treatment outcome. Previous research focused ex...

1 min read🔬 Clinical Trial

New Trial: Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms

MAGNETS is a prospective, randomized, parallel-design, sham-controlled clinical trial of accelerated, functional magnetic resonance imaging (fMRI)-guided intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (dlPFC)...

1 min read